ursolic acid has been researched along with Adjuvant Arthritis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, H; Choi, JK; Ha, YS; Jeong, NH; Kim, SH; Kwon, TK; Lee, B; Lee, JY; Lee, S; Lee, SR; Lee, SW; Park, PH; Rho, MC; Shin, TY; Yoo, J | 1 |
Abuzinadah, MF; Ahmad, A; Alkreathy, HM; Banaganapalli, B; Mujeeb, M | 1 |
Doshi, GM; Une, HD | 1 |
Baek, SY; Cho, ML; Kwok, SK; Lee, DG; Lee, J; Park, MK; Park, SH | 1 |
Amir, M; Aqil, M; Imam, SS; Jamal, M; Mir, SR; Mujeeb, M | 1 |
Han, HJ; Jeon, MJ; Kang, SY; Kim, HW; Kwon, YB; Lee, HJ; Lee, JH; Roh, DH; Seo, HS; Uh, DK; Yoon, SY | 1 |
Ahmad, SF; Bani, S; Khan, B; Qazi, GN; Satti, NK; Suri, KA | 1 |
7 other study(ies) available for ursolic acid and Adjuvant Arthritis
Article | Year |
---|---|
Anti-inflammatory effects of ursolic acid-3-acetate on human synovial fibroblasts and a murine model of rheumatoid arthritis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cells, Cultured; Collagen Type II; Cytokines; Disease Models, Animal; Fibroblasts; Humans; Immunoglobulin G; Inflammation Mediators; Male; Mice; Mice, Inbred DBA; Synovial Membrane; Th1 Cells; Th17 Cells; Triterpenes; Ursolic Acid | 2017 |
Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
Topics: Analgesics; Animals; Arthritis, Experimental; Cyclooxygenase 1; Cyclooxygenase 2; Drug Carriers; Drug Liberation; Female; Interleukin-1; Lipids; Male; Mice; Molecular Docking Simulation; Ocimum sanctum; Particle Size; Permeability; Plant Extracts; Protein Conformation; Rats; Rats, Wistar; Skin; Triterpenes; Tumor Necrosis Factor-alpha; Ursolic Acid | 2018 |
Carissa congesta Wight and Benincasa hispida (Thunb.) Cogn. as budding immunomodulatory agents.
Topics: Animals; Apocynaceae; Arthritis, Experimental; Cucurbitaceae; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Hemagglutination; Hypersensitivity, Delayed; Immunologic Factors; Male; Pentacyclic Triterpenes; Phagocytosis; Phytotherapy; Plant Extracts; Plant Roots; Plants, Medicinal; Rats, Wistar; Seeds; Sitosterols; Triterpenes; Ursolic Acid | 2016 |
Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation.
Topics: Animals; Arthritis, Experimental; Autoimmune Diseases; B-Lymphocytes; Cell Differentiation; Male; Mice; Mice, Inbred DBA; Th17 Cells; Triterpenes; Ursolic Acid | 2014 |
Transdermal potential and anti-arthritic efficacy of ursolic acid from niosomal gel systems.
Topics: Administration, Cutaneous; Analgesics; Animals; Arthritis, Experimental; Chemistry, Pharmaceutical; Drug Delivery Systems; Excipients; Foot; Gels; In Vitro Techniques; Irritants; Liposomes; Pain Measurement; Particle Size; Rats; Rats, Wistar; Skin Absorption; Triterpenes; Ursolic Acid | 2015 |
The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models.
Topics: Acute Disease; Animals; Antirheumatic Agents; Arthritis, Experimental; Cell Movement; Chronic Disease; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Leukocytes; Mice; Mice, Inbred ICR; Oldenlandia; Pain; Plant Extracts; Rats; Rats, Sprague-Dawley; Triterpenes; Ursolic Acid; Zymosan | 2008 |
Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Cestrum; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Interferon-gamma; Interleukin-2; Mice; Mice, Inbred BALB C; Mycobacterium; Plant Leaves; Prednisolone; Th1 Cells; Th2 Cells; Triterpenes; Tumor Necrosis Factor-alpha; Ursolic Acid | 2006 |